Biopharmaceutical Analysis

Jan 01, 2015
BioPharm International
Understanding and preventing protein aggregation is crucial to ensuring product quality and patient safety.
Dec 01, 2014
BioPharm International
The use of orthogonal methods to SEC is discussed and examples are presented showing how analytical ultracentrifugation, AF4, and SEC compare in aggregate quantitation.
Dec 01, 2014
BioPharm International
Implementing process analytical technology for bioprocessing presents unique challenges, but the recent emphasis on establishing a thorough understanding of the manufacturing process is a key enabler of PAT approaches.
Nov 01, 2014
BioPharm International
The ability to define a scientifically justified and statistically sound sampling procedure is a fundamental skill in modern systematic drug development.
Nov 01, 2014
BioPharm International
Defining critical parameters and processing large quantities of data can be a challenge.
Oct 01, 2014
BioPharm International
Adding light scattering to size-exclusion chromatography (SEC) can maximize the benefits of SEC.
Oct 01, 2014
BioPharm International
A quality-by-design approach that defines potential viral contaminants of source materials can be used to achieve viral clearance.
Sep 15, 2014
BioPharm International
By BioPharm International Editors
A Q&A on bioanalytical method integrity with Roger Hayes of MPI Research.
Sep 01, 2014
BioPharm International
Design space generation is encouraged in new product development.
Aug 15, 2014
BioPharm International
Industry players form Allotrope Foundation to solve analytical data management problems.
native1_300x100
lorem ipsum